The clinical application of whole-body diffusion-weighted imaging in the early assessment of chemotherapeutic effects in lymphoma: The initial experience

Magnetic Resonance Imaging

Volumn 30, Issue 2, 2012, Pages 165-170

  Chen, Yunbin ^a   Zhong, Jing ^a   Wu, Hui ^a   Chen, Ningbin ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apparent diffusion coefficient; Chemotherapeutic assessment; Non Hodgkin's lymphoma; Whole body diffusion weighted imaging

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ACCURACY; ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER MORPHOLOGY; CANCER SIZE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DRUG EFFICACY; FEMALE; HUMAN; IMAGE PROCESSING; MALE; NONHODGKIN LYMPHOMA; PHYSICAL PARAMETERS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR CELL; WHOLE BODY DIFFUSION WEIGHTED IMAGING; WHOLE BODY IMAGING;

ADULT; AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; EARLY DIAGNOSIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; LYMPHOMA, NON-HODGKIN; MALE; MELPHALAN; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; WHOLE BODY IMAGING;

ANIMALIA;

EID: 84855493221     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2011.09.019     Document Type: Article

References (26)

1. Zinzani P.L. Lymphoma: diagnosis, staging, natural history, and treatment strategies. Semin Oncol 2005, 32:S4-S10.
2. Koh D.M., Padhani A.R. Diffusion-weighted MRI: a new functional clinical technique for tumor imaging. Br J Radiol 2006, 79:633-635.
3. Even-Sapir E., Israel O. Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma. Eur J Nucl Med Mol Imaging 2003, 30(Suppl 1):S65-S81.
4. Juweid M.E., Wiseman G.A., Vose J.M., et al. Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. J Clin Oncol 2005, 23:4652-4661.
5. Mikhaeel N.G., Hutchings M., Fields P.A., et al. FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Ann Oncol 2005, 16:1514-1523.
6. Miles K.A., Griffiths M.R., Keith C.J. Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography. Eur J Nucl Med Mol Imaging 2006, 33:22-28.
7. Rajendran J.G., Wilson D.C., Conrad E.U. [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging 2003, 30:695-704.
8. Spaepen K., Stroobants S., Dupont P. [(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?. Eur J Nucl Med Mol Imaging 2003, 30:682-688.
9. Takahara T., Imai Y., Yamashita T., et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. J Radiat Med 2004, 22(4):275-282.
10. Komori T., Narabayashi I., Matsumura K., et al. 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. J Ann Nucl Med 2007, 21:209-215.
11. Antoun H., Popa L., Momo J.A., et al. Whole body diffusion weighted MRI compared to 18F-FDG position emission tomography for the detection and localization of malignant lesions 2008, [Abstract 2715].
12. Nakanishi K., Kobayashi M., Nakaguchi K., et al. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. J Megn Reson Med Sci 2007, 6(3):147-155.
13. Ohno Y., Koyama H., Nogami M., et al. Whole-body MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients. J Magn Reson Imaging 2007, 26:498-509.
14. Ohno Y., Koyama H., Onishi Y., et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment - utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. J Radiol 2008, 248:643-654.
15. Cui Y., Zhang X.P., Sun Y.S., et al. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. J Radiol 2008, 248(3):894-900.
16. Reichardt W., Juettner E., Uhl M., et al. Diffusion-weighted imaging as predictor of therapy response in an animal model of Ewing sarcoma. J Invest Radiol 2009, 44(5):298-303.
17. Roth Y., Tichler T., Kostenich G., et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. J Radiol 2004, 232(3):685-692.
18. Kim S., Loevner L., Quon H., et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. J Clin Cancer Res 2009, 15(3):986-994.
19. Theilmann R.J., Borders R., et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. J Neoplasia 2004, 6(6):831-837.
20. Li S., Xue H.D., Wang X.H., et al. MR diffusion weighted imaging for evaluation of radiotherapeutic effects on rabbit VX2 tumor model. J Chin Med Sci 2008, 23(3):172-177.
21. Huang M.Q., Pickup S., Nelson D.S., et al. Monitoring response to chemotherapy of non-Hodgkin's lymphoma xenografts by T2-weighted and diffusion-weighted MRI. NMR Biomed 2008, 21:1021-1029.
22. Schag C.C., Heinrich R.L., Ganz P.A. Karnofsky performance status revisited: reliability, validity, and guideline. J Clin Oncol 1984, 2:187-193.
23. Li S., Sun F., Jin Z.Y., et al. Whole-body diffusion-weighted imaging: technical improvement and preliminary results. J Magn Reson Imaging 2007, 26:1139-1144.
24. Stephen B.E., David R.B., Carolyn C.C., et al. AJCC cancer staging handbook. American Joint Committee on Cancer 2010, 671. 7th ed.
25. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92:205-216.
26. Ballon D., Watts R., Dyke J.P., et al. Imaging therapeutic response in human bone marrow using rapid whole-body MRI. J Magn Reson Med 2004, 52(6):1234-1238.